Also trades as: IBX.AX (ASX) · $vol 0M
IBXXF OTC
Imagion Biosystems Limited
1W: +0.0%
1M: +0.0%
3M: -60.0%
YTD: +20.0%
1Y: -20.0%
3Y: -97.3%
5Y: -99.5%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$4M
-218.1% ▼
Capital Expenditures
$4
+0.0% ▲
5Y CAGR: -77.5%
Free Cash Flow
-$4M
-218.1% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$628K
-125.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$6M | -$10M | -$12M | -$2M | -$4M |
| Depreciation & Amort. | $404K | $1M | $1M | $392K | $9K |
| Stock-Based Comp. | $498K | $653K | $463K | $12K | $0 |
| Change in Working Capital | $48K | -$30K | $2M | $73K | -$740K |
| Other Non-Cash Items | $1M | $9M | $359K | $320K | $997K |
| Operating Cash Flow | -$5M | -$8M | -$8M | -$1M | -$4M |
| — Investing Activities — | |||||
| Capital Expenditures | -$219K | -$507K | -$190K | $84K | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$91K | $39K | $0 | $0 | $0 |
| Investing Cash Flow | -$310K | -$469K | -$190K | $84K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$359K | -$965K | $4M | $677K | $0 |
| Stock Repurchased | -$6K | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | -$2M | -$192K | $0 |
| Financing Cash Flow | $5M | -$962K | $4M | $4M | $3M |
| Net Change in Cash | $193K | -$9M | -$4M | $2M | -$628K |
| Cash End of Period | $13M | $4M | $227K | $3M | $2M |
| Free Cash Flow | -$5M | -$9M | -$9M | -$1M | -$4M |